|
C1ORF43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.89386309254769E-13 |
| Normal-vs-Stage2 |
3.82970000000205E-05 |
| Normal-vs-Stage3 |
6.3563999619376E-09 |
| Normal-vs-Stage4 |
7.65080000020291E-07 |
| Stage1-vs-Stage2 |
9.356400E-01 |
| Stage1-vs-Stage3 |
8.208800E-01 |
| Stage1-vs-Stage4 |
9.895900E-02 |
| Stage2-vs-Stage3 |
8.220000E-01 |
| Stage2-vs-Stage4 |
1.483560E-01 |
| Stage3-vs-Stage4 |
1.602840E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85438339631128E-13 |
| Normal-vs-AfricanAmerican |
2.815300E-04 |
| Normal-vs-Asian |
6.06049999962721E-07 |
| Caucasian-vs-AfricanAmerican |
4.066800E-01 |
| Caucasian-vs-Asian |
3.427200E-01 |
| AfricanAmerican-vs-Asian |
9.150600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76589999956178E-07 |
| Normal-vs-Female |
3.33066907387547E-16 |
| Male-vs-Female |
3.209800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.54143406109142E-12 |
| Normal-vs-Age(41-60Yrs) |
6.7434946515732E-11 |
| Normal-vs-Age(61-80Yrs) |
3.91449994641135E-09 |
| Normal-vs-Age(81-100Yrs) |
9.155700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.004200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.128200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.603200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.814820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.271600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.865200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.793200E-01 |
| Classical-VS-Follicular |
9.393600E-01 |
| Classical-VS-Other |
3.725600E-01 |
| Classical-VS-Normal |
1.62669877568078E-12 |
| Tall-VS-Follicular |
8.691000E-01 |
| Tall-VS-Other |
3.422600E-01 |
| Tall-VS-Normal |
6.40459999999843E-05 |
| Follicular-VS-Other |
4.801000E-01 |
| Follicular-VS-Normal |
4.63809999962095E-07 |
| Other-VS-Normal |
2.355400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24820154212557E-11 |
| Normal-vs-N1 |
3.647300E-04 |
| N0-vs-N1 |
5.302000E-01 |
|
|
